Therapy of Type 2 Diabetes

The Clinical Practice Guidelines of the German Diabetes Society/Deutsche Diabetes Gesellschaft (DDG) together with the German Society for Internal Medicine/Deutschen Gesellschaft für Innere Medizin (DGIM) are based on the contents of the National Treatment Guideline (Nationale Versorgungsleitlinie (NVL)) “Type 2 Diabetes” [ 1 ]. The modifications in therapy and their justifications made in the present Clinical Practice Guidelines were updated on the basis of new randomized controlled trials (RCTs) and meta-analyses. In order to improve the work with the extensive practice guideline in practice, the authors have decided to move the individual glucose-lowering pharmaceuticals and some algorithms in the current practice guideline to a detailed appendix. The corresponding bibliography can also be found in the appendix. Publication History Article published online: 15 July 2022 © 2022. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany